Urologic Oncology Seminars and Original Investigations

Elsevier BV

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Urologic Oncology Seminars and Original Investigations is a journal published by Elsevier BV in United States. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 3,340 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier BV
ISSN
1873-2496 · 1078-1439
Country
United States
Access
Not open access / not declared
Declared publication charge
3,340 USD
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2002-01-01
  • PUBMED · 1998-03-04
Indexing
MEDLINE · PUBMED
APC
3,340 USD
Declared review time (DOAJ)
—
Actual review time (measured)
113 days received→accepted — computed from PubMed (n=89)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

7484

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

107

i10-index

3000

From OpenAlex open data (CC0).

Editorial & policy4
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
56%
ORCID iDs in current deposits
46%
Deposits licence metadata at Crossref
✓
Identity & continuity4
Alternate titles
Urologic oncology: seminars and original investigationsUrol. oncol.Urol OncolSeminars and original investigations
Source type
journal
NLM unique ID (PubMed)
9805460
Society affiliations
Society of Urologic Oncology
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Bladder and Urothelial Cancer Treatments
  • Bladder and Urothelial Cancer Treatments
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Treatment and Research
  • Renal cell carcinoma treatment
  • Renal cell carcinoma treatment
Show all subjects (50)
  • Urinary and Genital Oncology Studies
  • Urinary and Genital Oncology Studies
  • Diverse Scientific and Economic Studies
  • Diverse Scientific and Economic Studies
  • Human auditory perception and evaluation
  • Human auditory perception and evaluation
  • Multiple and Secondary Primary Cancers
  • Multiple and Secondary Primary Cancers
  • Testicular diseases and treatments
  • Testicular diseases and treatments
  • Renal and related cancers
  • Renal and related cancers
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Urinary Tract Infections Management
  • Urologic and reproductive health conditions
  • Urologic and reproductive health conditions
  • Urinary Tract Infections Management
  • Advanced Radiotherapy Techniques
  • Advanced Radiotherapy Techniques
  • Urinary Bladder and Prostate Research
  • Urinary Bladder and Prostate Research
  • Inflammatory Biomarkers in Disease Prognosis
  • Inflammatory Biomarkers in Disease Prognosis
  • Educational Robotics and Engineering
  • Educational Robotics and Engineering
  • Ferroptosis and cancer prognosis
  • Ferroptosis and cancer prognosis
  • Urological Disorders and Treatments
  • Urological Disorders and Treatments
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Cancer survivorship and care
  • Cancer survivorship and care
  • Genital Health and Disease
  • Genital Health and Disease
  • Esophageal Cancer Research and Treatment
  • Esophageal Cancer Research and Treatment
  • Cancer, Lipids, and Metabolism
  • Cancer, Lipids, and Metabolism
  • Epigenetics and DNA Methylation
  • Epigenetics and DNA Methylation

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: